Takeda Pharmaceutical Company Stocks List Ranked

	Symbol	Grade	Name	% Change
	TAK	F	Takeda Pharmaceutical Company Limited	0.75

Symbol	Grade	Name	Weight
BBH	B	Market Vectors Biotech ETF	16.98
IBBQ	C	Invesco Nasdaq Biotechnology ETF	11.62
IBB	C	iShares Nasdaq Biotechnology Index Fund	11.39
FBT	D	First Trust Amex Biotech Index Fund	10.53
BIS	D	ProShares UltraShort Nasdaq Biotechnology	9.95

Compare ETFs

Compare BBH to FBT Compare IBB to FBT Compare IBBQ to BIS

Date	Stock	Title
Apr 29	TAK	Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround

Takeda Pharmaceutical Company: The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical and biopharmaceutical company. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 49,578 employees worldwide and achieved US $19.299 billion in revenue during the 2018 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.
In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.